Showing results (61-70 of 344) with videos related to
Sort By:
Pageof 35
Journal of Market Access & Health Policy|April 25, 2025
ARM's Perspective on the First Joint Clinical Assessments for ATMPs: Challenges and Opportunities on the Path AheadPaolo Morgese, Stephen Majors, Dilip PatelJournal of Market Access & Health Policy|June 16, 2023
Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursementBérengère Macabeo, Liam Wilson, Jianwei Xuan, et al.Journal of Market Access & Health Policy|February 23, 2026
Adopting a Societal Perspective in Health-Economic Evaluation: Analysis of Nine HTA Methodological Guidelines on How to Integrate Societal CostsChloé Gervès-Pinquié, Hortense Nanoux, Sarah Akarkoub, et al.Journal of Market Access & Health Policy|March 28, 2024
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and CollaboratorsThomas Desmet, Elaine Julian, Walter Van Dyck, et al.Journal of Market Access & Health Policy|March 27, 2026
Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in ThailandPiyapat Owat, Chaoncin Sooksriwong, Hataiwan Ratanabunjerdkul, et al.Journal of Market Access & Health Policy|April 25, 2024
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver DiseaseMichal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, et al.Journal of Market Access & Health Policy|September 11, 2023
Patient perceptions of copay card utilization and policiesDimika Cavalier, Bridget Doherty, Gabrielle Geonnotti, et al.Journal of Market Access & Health Policy|December 12, 2022
Innovative technologies for reverse total shoulder arthroplasty in Australia: Market access challenges and implications for patients, decision-makers, and manufacturersMutsa Gumbie, Michelle Costa, Michael Erb, et al.Journal of Market Access & Health Policy|May 27, 2016
Benefits of probabilistic sensitivity analysis - a review of NICE decisionsErpur Adalsteinsson, Mondher ToumiJournal of Market Access & Health Policy|May 27, 2016
The value of quantitative patient preferences in regulatory benefit-risk assessmentMart Oude Egbrink, Maarten IJzermanPageof 35